<DOC>
	<DOCNO>NCT00220701</DOCNO>
	<brief_summary>This 12-week double-blind placebo-controlled study Escitalopram treatment dysthymic Disorder ( low-grade chronic depression ) , 12 week open-label extension phase . It hypothesize Escitalopram superior placebo improve depression , well psychosocial , temperamental , cognitive functioning .</brief_summary>
	<brief_title>Escitalopram Treatment Dysthymic Disorder , Double Blind</brief_title>
	<detailed_description>This 12-week double-blind placebo-controlled study Escitalopram treatment Dysthymic Disorder ( low-grade chronic depression ) , 12 week open-label extension phase . Flexible dose maximum 40 mg per day use . It hypothesize Escitalopram superior placebo improve depression , well psychosocial , temperamental , cognitive functioning . Blood cytokine level also measure week 0 , 12 , 24 determine relationship depressive symptom improvement .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Dysthymic Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Male female outpatient 1865 year age . Patients Diagnostic Statistical Manual , fourth edition ( DSMIV ) diagnosis dysthymic disorder . Subject must consider reliable . Patients total 12 high Hamilton Depression Scale ( 24 item ) baseline . Patients DSMIV diagnosis Delirium , Dementia , Amnestic , Cognitive Disorders . Patients plan produce pregnancy within next 6 month , patient pregnant nursing woman . Patients history nonresponse two sufficient trial antidepressant medication ( define Table 1 ) . Patients principal diagnosis meeting DSMIV criterion : Major Depressive Disorder , current Bipolar Disorder cyclothymia .Schizophrenia , Delusional ( Paranoid ) Disorders Psychotic Disorders elsewhere classify . Anorexia Nervosa Bulimia Patients , within past 6 month , meet DSMIV criterion abuse dependence drug , include alcohol , exclude caffeine tobacco . Patients take psychotropic medication herbal preparation putative psychotropic effect within 7 day prior Visit 2 . Patients take monoamine oxidase inhibitor ( type antidepressant ) ( MAOI ) must washout period 14 day prior visit 2 , patient take fluoxetine must washout period least 4 week prior Visit 2 . Patients would pose serious risk suicide course study , evidence one following : Report specific plan kill A score 3 high Hamilton Depression Rating Scale item # 3 rat treat clinician Week 0 , ( indicative active suicidal thought behavior ) A suicide attempt within past 12 month require emergency room visit , medical psychiatric hospitalization , otherwise deem lifethreatening ( e.g . overdose &gt; 1 week 's dose medication . Patients unstable medical condition , acute hyperthyroidism , uncorrected hypothyroidism , undiagnosed fever , uncontrolled angina , serious medical illness , include cardiovascular , hepatic , respiratory , hematological , endocrinologic neurologic disease , clinically significant laboratory abnormality . Patients lack capacity prove informed consent 50 % great decrease HDRS total score visit 2 visit 3 CGIImprovement score 1 ( `` much improve '' ) 2 ( `` much improve '' ) Visit 3 Patients receive CGI Improvement score 6 ( `` much bad '' ) 7 ( `` much bad '' ) two consecutive visit withdrawn study . Patients meet criterion Major Depressive Disorder time course study withdrawn study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Dysthymic Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Chronic Depression</keyword>
	<keyword>Escitalopram</keyword>
</DOC>